Hims & Hers Health (HIMS) Other Operating Expenses (2020 - 2026)
Hims & Hers Health's (HIMS) quarterly Other Operating Expenses came in at $318.5 million in Q1 2026, up 8.24% year-on-year from $294.3 million in Q1 2025, and little changed quarter-over-quarter from $318.1 million in Q4 2025.
Hims & Hers Health (HIMS) Other Operating Expenses (2020 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Other Operating Expenses across 7 years of filings, most recently posting $318.5 million for Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $318.5 million, up 8.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 24.29% YoY), and the FY2025 annual result was $1.2 billion, up 39.45% from the prior year.
- Other Operating Expenses came in at $318.5 million for Q1 2026 at Hims & Hers Health, roughly flat from $318.1 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $318.5 million in Q1 2026 to a low of $63.8 million in Q1 2022.
- The 5-year median for Other Operating Expenses is $169.3 million (2024), against an average of $194.4 million.
- Across the five-year window, Other Operating Expenses jumped 178.91% in 2022 and grew 8.24% in 2026, its largest moves.
- Hims & Hers Health's Other Operating Expenses stood at $108.1 million in 2022, then soared by 46.89% to $158.7 million in 2023, then soared by 75.87% to $279.2 million in 2024, then climbed by 13.95% to $318.1 million in 2025, then climbed by 0.12% to $318.5 million in 2026.
- The last three Other Operating Expenses figures came in at $318.5 million (Q1 2026), $318.1 million (Q4 2025), and $309.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318.51 Mn |
| Dec 31, 2025 | 318.12 Mn |
| Sep 30, 2025 | 309.00 Mn |
| Jun 30, 2025 | 284.35 Mn |
| Mar 31, 2025 | 294.27 Mn |
| Dec 31, 2024 | 279.17 Mn |
| Sep 30, 2024 | 229.80 Mn |
| Jun 30, 2024 | 186.38 Mn |
| Mar 31, 2024 | 169.30 Mn |
| Dec 31, 2023 | 158.73 Mn |
| Sep 30, 2023 | 147.69 Mn |
| Jun 30, 2023 | 136.45 Mn |
| Mar 31, 2023 | 123.43 Mn |
| Dec 31, 2022 | 108.06 Mn |
| Sep 30, 2022 | 100.21 Mn |
| Jun 30, 2022 | 77.94 Mn |
| Mar 31, 2022 | 63.78 Mn |
| Dec 31, 2021 | 56.55 Mn |
| Sep 30, 2021 | 51.10 Mn |
| Jun 30, 2021 | 27.94 Mn |